Nitrogen-based drugs are not essential for blockade of monoamine transporters

Synapse

Volumn 24, Issue 4, 1996, Pages 340-348

  Madras, Bertha K ^a   Pristupa, Zdenek B ^b   Niznik, Hyman B ^b   Liang, Anna Y ^c   Blundell, Paul ^c   Gonzalez, Mario D ^c   Meltzer, Peter C ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c ORGANIX INC   (United States)

Author keywords

Antidepressants; Dopamine transporter; Methylphenidate; Monoamines; Norepinephrine transporter; Serotonin transporter

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ALPHA ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; COCAINE; DOPAMINE RECEPTOR; METHYLPHENIDATE; NISOXETINE; NORADRENALIN; SEROTONIN RECEPTOR; TROPANE DERIVATIVE; TROPOXANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DEPRESSION; DOPAMINE RELEASE; DRUG BINDING; DRUG MECHANISM; DRUG UPTAKE; MONKEY; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CARRIER PROTEINS; CITALOPRAM; COCAINE; COS CELLS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FLUOXETINE; HUMANS; MACACA FASCICULARIS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NITROGEN; NOREPINEPHRINE; PUTAMEN; RADIOLIGAND ASSAY;

EID: 0029965036     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199612)24:4<340::AID-SYN4>3.0.CO;2-D     Document Type: Article

References (54)

1. Amara, S.G., and Kuhar, M.J. (1993) Neurotransmitter transporters: Recent progress. Ann. Rev. Neurosci., 16:73-93.
2. Barker, E.L., Kimmel, H.L., and Blakely, R.D. (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol. Pharmacol., 46:799-807.
3. Bergman, J., Madras, B.K., Johnson, S.E., and Spealman, R.D. (1989) Effects of cocaine and related drugs in nonhuman primates: III. Self-administration by squirrel monkeys. J Pharmacol. Exp. Ther., 251:150-155.
4. Blakely, R.D., Berson, H.E., Fremeau, R.T., Jr., Caron, M.G., Peek, M.M., Prince, H.K., and Bradley, C.C. (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature, 354:66-70.
5. Bradberry, C.W., Roth, R.H. (1989) Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett., 103:97-102.
6. Brownell, A.-L., Elmaleh, D.E., Meltzer, P.C., Shoup, T.M., Brownell, G.L., Fischman, A.J., Madras, B.K. (1996) Cocaine congeners as PET imaging probes for dopamine terminals. J. Nucl. Med., 37: 1186-1192.
7. Buck, K.J., and Amara, S.G. (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-14-phenylpyridinium. Proc. Natl. Acad. Sci. U.S.A., 91:12584-12588.
8. 3H]CFT in monkey brain. Synapse, 5:189-195
9. Carroll, F.I., Gao, Y., Rahman, M.A., Abraham, P., Parham, K., Lewin, A.H., Boja, J.W., and Kuhar, M.J. (1991) Synthesis, ligand binding, QSAR, and CoMFA study of 3b-(p- substituted phenyl)tropane-2b-carboxylic acid methyl esters. J. Med. Chem., 34:2719-2725.
10. Cascieri, M.A., Huang, R.-R.C., Fong, T.M., Cheung, A.H., Sadowski, S., Ber, E., and Strader, C.D. (1992) Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol. Pharmacol., 41:1096-1099.
11. Church, W.H., Justice, J.B., Jr., Byrd, L.D. (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur. J. Pharmacol. 139: 345-348.
12. Clarke, R.L., Daum, S.J., Gambino, A.J., Aceto, M.D., Pearl, J., Levitt, M., Cumiskey, W.R., and Bogado, E.F. (1973) Compounds affecting the central nervous system. 4.3b- phenyltropane-2-carboxylic esters and analogs. J. Med. Chem., 16:1260-1267.
13. Coyle, J.T., and Snyder, S.H. (1969) Science, 166:899.
14. Dougherty, D.A. (1996) Cation-π interactions in chemistry and biology: A new view of benzene, phe, tyr, and trp. Science, 271:163-168.
15. Fischman, A.J., Babich, J.W., Elmaleh, D.E., Barrow, S.A., Meltzer, P.C., and Madras, B.K. SPECT imagingin normal and MPTP treated rhesus monkeys. J. Nucl. Med., in press.
16. 11C-WIN 35,428 reveals marked decline in mild Parkinson's disease. Ann. Neurol., 34: 423-431.
17. Giros, B., Wang, Y.M., Suter, S., McLeskey, S.B., Pifl, C., and Caron, M.G. (1994) Delineaetion of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem., 269:15985-15988.
18. Giros, B., el Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., and Caron, M.G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol., 42:383-390.
19. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379:606-612, 1996.
20. Gracz, L., and Madras, B.K. (1995) [3H]WIN 35,428 binds to multiple charged states of the solubilized dopamine transporter in primate brain. J. Pharmacol. Exp. Ther., 273:1224-1234.
21. Hurd, Y.L., and Ungerstedt, U. (1989) Cocaine: An in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse, 3: 48-54.
22. Iversen, L.L., (1975) Uptake process of biogenic amines. In: Handbook of Psychopharmacology. L.L. Iversen, S.D. Iversen, S.H. Snyder, eds. Plenum, New York, pp. 381-442.
23. Kalivas, P.W., and Duffy, P. (1990) Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse, 5:48-58.
24. Kaufman, M.J., and Madras, B.K. (1991) Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's diseased striatum. Synapse, 9:43-49.
25. 125I]RTI-55 in monkey brain: II. Ex vivo autoradiographic distribution. Synapse, 12: 99-111.
26. Kilty, J.E., Lorang, D., and Amara, S.G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science, 254:578-579.
27. Kilty, J.E., and Amara, S.G. (1992) Families of twelve transmembrane domain transporters. [Review] Current Opinion in Biotechnology, 3:675-682.
28. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D.M., and Uhl, G.R. (1992) Dopamine transporter site-directed mutations differentially alter substrate transporter and cocaine binding. Proc. Natl. Acad. Sci. U.S.A, 89:7782-7785.
29. Kosikowski, A.P., Saiah, M.K.E., Eddine, M.K., Bergman, J.S., and Johnson, K.M. (1994). Structure-activity relationship studies of N-sulfonyl analogs of cocaine: Role of ionic interactions in cocaine binding. J. Med. Chem., 37:3440-3442.
30. 123I]b-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse, 13:295-309.
31. Lee, F.J., Pristupa, Z.B., Ciliax, B., Levey, A.I., and Niznik, H.B. (1996) J. Biol. Chem., in press.
32. 3H]Cocaine binding sites in caudate- putamen. J. Pharmacol. Exp. Ther., 251:131-141.
33. 3H]2b-carbomethoxy-3b-(4-fluorophenyl)tropane. Mol. Pharmacol., 36: 518-524.
34. 3H]cocaine receptors. Pharmacol. Biochem. Behav., 35:949-953.
35. Madras, B.K., Reith, M.E.A., Meltzer, P.C., Dutta, A.K. (1994) O-526, A piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen. Eur. J. Pharmacol., 267:167-173.
36. Madras, B.K., Pristupa, Z. Niznik, H.B., Liang, A.Y., Meltzer, P.C. Presented at the annual meeting of the College on Problems Drug Dependence, June 1996 and Soc. Neurosci. Abst., 22:509, 1996a.
37. 99mTechnetium probe to label the dopamine transporter in brain by SPECT imaging. Synapse, 22:239-246.
38. Meltzer, P.C., Liang, A.Y., Brownell, A.-L., Elmaleh, D.R., and Madras, B.K. (1993) Substituted 3-phenyltropane analogs of cocaine: Synthesis, inhibition of binding at cocaine recognition sites and positron emission tomography (PET) imaging. J. Med. Chem., 36:855-862.
39. Meltzer, P.C., Liang, A.Y., and Madras, B.K. (1994) The discovery of an unusually selective and novel cocaine analog: Difluoropine (O-620). Synthesis and inhibition of binding at cocaine recognition sites. J. Med. Chem., 37:2001-2010.
40. Meltzer, P.C., Liang, A.Y., Madras, B.K. (1996) 2-Carbomethoxy-3-(diarylmethoxy)-1αH,5αH-tropane analogs: Synthesis and inhibition of binding at the dopamine transporter and comparison with piperazines of the GBR series. J. Med. Chem., 39: 371-379.
41. Pacholczyk, T., Blakely, R.D., and Amara, S.G. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature, 350:350-354.
42. 3H]GBR 12, 935 binding. Mol. Pharmacol., 45:125-35.
43. Ramamoorthy, S., Bauman, A.L., Moore, K.R., Han, H., Yang-Feng, T., Chang, A.S., Ganapathy, V., and Blakely, R.D. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. U.S.A., 90:2542-2546.
44. Reith, M.E.A., Meisler, B.E., Sershen, H., and Lajtha, A. (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sties in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol., 35, 1123-1129.
45. Ritz, M.C., Lamb, R.J., Goldberg, S.R., and Kuhar, M.J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science, 237:1219-1223.
46. Schildkraut, J.J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. J. Psychiatry, 122: 509-522.
47. Schwartz, T.W., and Rosenkilde, M.M. (1996) Is there a "lock" for all agonist 'keys' in 7TM receptors? Trends in Pharmacol. Sci., 17:213-216.
48. Seeman, P. (1993) Receptor Tables, SZ Research, Toronto, Canada.
49. Simantov, R. (1995) Neurotransporters: Regulation, involvement in neurotoxicity, and the usefulness of antisense nucleic acids. Biochem. Pharmacol., 50:435-442.
50. Spealman, R.D., Madras, B.K., and Bergman, J. (1989) Effects of cocaine and related drugs in nonhuman primates: II. Psychomotorstimulant effects in squirrel monkeys. J. Pharmacol. Exp. Ther., 251: 142-149.
51. Strader, C.D., Sigal, I.S., Candelore, M.R., Rands, E., Hill, W., and Dixon, R.A.F. (1988) Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptors have different roles in receptor function. J. Biol. Chem., 263:10267-10271.
52. Strader, C.D., Gaffney, T., Sugg, E.E., Candelore, M.R., Keys, R., Patchett, A.A., and Dixon, R.A.F. (1991) Allele-specific activation of genetically engineered receptors. J. Biol. Chem., 266:5-8.
53. Strader, C.D., Fong, T.M., Tota, M.R., Underwood, D., and Dixon, R.A.F. (1994) Structure and function of G-protein-coupled receptors. Ann. Rev. Biochem., 63:101-132, 1994.
54. 11C]WIN 35,428. Synapse, 15:130-142.